Literature DB >> 18172531

Endovascular exclusion of mycotic aortic aneurysm.

Thomas J Takach1, Peter N Kane, Jeko M Madjarov, Jeremiah H Holleman, Francis Robicsek, Timothy S Roush.   

Abstract

The presence of prohibitive risk may preclude usual surgical management. Such was the case for a critically ill, 60-year-old woman who presented with concomitant, life-threatening conditions. The patient presented with acute central cord syndrome and lower-extremity paraplegia after completing a 6-week course of intravenous antibiotics for methicillin-sensitive Staphylococcus aureus bacteremia and osteomyelitis of the thoracic spine. Radiologic examination revealed bony destruction of thoracic vertebrae T4 through T6, impingement on the spinal cord and canal by an inflammatory mass, and a separate 2.5-cm mycotic aneurysm of the infrarenal aorta. The clinical and radiologic findings warranted immediate decompression and stabilization of the spinal cord, aneurysmectomy, and vascular reconstruction. However, the severely debilitated patient could not tolerate 2 simultaneous open procedures. She underwent emergent endovascular exclusion of the mycotic aneurysm with a stent-graft, followed immediately by laminectomy and stabilization of the thoracic spine. Intraoperative microbiology specimens showed no growth. The patient was maintained on prophylactic antibiotic therapy for 6 months. Fourteen months postoperatively, her neurologic function was near full recovery, and neither surveillance blood cultures nor radiologic examinations showed a recurrence of infection or aneurysm. Although the long-term outcome of endovascular stent-grafts in the treatment of culture-negative mycotic aneurysms is unknown, the use of these grafts in severely debilitated patients can reduce operative risk and enable recovery in the short term.

Entities:  

Keywords:  Aneurysm, infected/diagnosis/therapy; aortic aneurysm/pathology/therapy; aortic diseases/physiopathology/therapy; blood vessel prosthesis implantation; critical care/methods; diagnosis, differential; infection/complications; risk assessment; stents; treatment outcome; vascular surgical procedures/methods

Mesh:

Year:  2007        PMID: 18172531      PMCID: PMC2170503     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  23 in total

1.  Endovascular repair of Salmonella-infected abdominal aortic aneurysms: a word of caution.

Authors:  Thomas L Forbes; Gregory E J Harding
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

Review 2.  Intramural hematoma and penetrating atherosclerotic ulcer of the aorta.

Authors:  Thoralf M Sundt
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

3.  Stent-graft treatment of infected aortic and arterial aneurysms.

Authors:  Kwang-Hun Lee; Jong Yun Won; Do Yun Lee; Donghoon Choi; Won-Heum Shim; Byung Chul Chang; Sang Joon Park
Journal:  J Endovasc Ther       Date:  2006-06       Impact factor: 3.487

4.  Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases.

Authors:  B T Müller; O R Wegener; K Grabitz; M Pillny; L Thomas; W Sandmann
Journal:  J Vasc Surg       Date:  2001-01       Impact factor: 4.268

5.  Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center.

Authors:  Gustavo S Oderich; Thomas C Bower; Kenneth J Cherry; Jean M Panneton; Timothy M Sullivan; Audra A Noel; Michele Carmo; Stephen Cha; Manju Kalra; Peter Gloviczki
Journal:  J Vasc Surg       Date:  2006-06       Impact factor: 4.268

6.  Repair of a mycotic aneurysm of the infrarenal aorta in a patient with HIV, using a Palmaz stent and autologous femoral vein graft.

Authors:  Peter P Patetsios; William Shutze; Bridget Holden; Wilson V Garrett; Gregory J Pearl; Bertram L Smith; Dennis R Gable; Bradley R Grimsley
Journal:  Ann Vasc Surg       Date:  2002-04-18       Impact factor: 1.466

7.  Suprarenal mycotic aneurysm exclusion using a stent with a partial autologous covering.

Authors:  P Madhavan; C O McDonnell; M O Dowd; S A Sultan; M Doyle; M P Colgan; N McEniff; M Molloy; D J Moore; G D Shanik
Journal:  J Endovasc Ther       Date:  2000-10       Impact factor: 3.487

8.  Endovascular treatment and complete regression of an infected abdominal aortic aneurysm.

Authors:  Christoph Berchtold; Charis Eibl; Matthias H Seelig; Pedi Jakob; Klaus Schönleben
Journal:  J Endovasc Ther       Date:  2002-08       Impact factor: 3.487

9.  Limitations of endovascular treatment with stent-grafts for active mycotic thoracic aortic aneurysm.

Authors:  Masaki Ishida; Noriyuki Kato; Tadanori Hirano; Takatsugu Shimono; Fuyuhiko Yasuda; Kuniyoshi Tanaka; Isao Yada; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2002 May-Jun       Impact factor: 2.740

10.  Midterm follow-up of penetrating ulcer and intramural hematoma of the aorta.

Authors:  Shawn L Tittle; Raymond J Lynch; Patricia E Cole; Harsimran S Singh; John A Rizzo; Gary S Kopf; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2002-06       Impact factor: 5.209

View more
  2 in total

1.  Successful emergency endovascular treatment of juxtarenal and infrarental mycotic aortic aneurysms in patients with small diameter aortae using Cook(®) Zenith ESLE Stentgrafts.

Authors:  Y C Chan; A C Ting; W K Yiu; S W Cheng
Journal:  World J Emerg Med       Date:  2012

2.  Infectious or noninfectious? Ruptured, thrombosed inflammatory aortic aneurysm with spondylolysis.

Authors:  Ludomir Stefańczyk; Marcin Elgalal; Andrzej Papiewski; Wojciech Szubert; Piotr Szopiński
Journal:  Cardiovasc Intervent Radiol       Date:  2012-09-13       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.